izpis_h1_title_alt

Rehoming and other refinements and replacement in procedures using golden hamsters in SARS-CoV-2 vaccine research
ID Štrbenc, Malan (Avtor), ID Kuhar, Urška (Avtor), ID Lainšček, Duško (Avtor), ID Orehek, Sara (Avtor), ID Slavec, Brigita (Avtor), ID Krapež, Uroš (Avtor), ID Malovrh, Tadej (Avtor), ID Majdič, Gregor (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (933,02 KB)
MD5: F3BCC75B5BDE711662C53F04F9171E69
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2076-2615/13/16/2616 Povezava se odpre v novem oknu

Izvleček
Effective vaccines are needed to fight the COVID-19 pandemic. Forty golden hamsters were inoculated with two promising vaccine candidates and eighteen animals were used in pilot trials with viral challenge. ELISA assays were performed to determine endpoint serum titres for specific antibodies and virus neutralisation tests were used to evaluate the efficacy of antibodies. All tests with serum from vaccinated hamsters were negative even after booster vaccinations and changes in vaccination protocol. We concluded that antibodies did not have sufficient neutralising properties. Refinements were observed at all steps, and the in vitro method (virus neutralisation test) presented a replacement measure and ultimately lead to a reduction in the total number of animals used in the project. The institutional animal welfare officer and institutional designated veterinarian approved the reuse or rehoming of the surplus animals. Simple socialization procedures were performed and ultimately 19 animals were rehomed, and feedback was collected. Recently, FELASA published recommendations for rehoming of animals used for scientific and educational purposes, with species-specific guidelines, including mice, rats, and rabbits. Based on our positive experience and feedback from adopters, we concluded that the rehoming of rodents, including hamsters, is not only possible, but highly recommended.

Jezik:Angleški jezik
Ključne besede:vaccines, mesocricetus, Models, animal, SARS-CoV-2
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:VF - Veterinarska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:16 str.
Številčenje:Vol. 13, iss. 16, [art. no.] 2616
PID:20.500.12556/RUL-148332 Povezava se odpre v novem oknu
UDK:636.09:578
ISSN pri članku:2076-2615
DOI:10.3390/ani13162616 Povezava se odpre v novem oknu
COBISS.SI-ID:161400579 Povezava se odpre v novem oknu
Datum objave v RUL:16.08.2023
Število ogledov:453
Število prenosov:38
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Animals
Skrajšan naslov:Animals
Založnik:MDPI AG
ISSN:2076-2615
COBISS.SI-ID:519120409 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:16.08.2023

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0053
Naslov:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0092
Naslov:Zdravje živali, okolje in varna hrana

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0176
Naslov:Sintezna biologija in imunologija

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:V4-2038
Naslov:DNK cepiva in peptidnih inhibitorji proti SARS-CoV-2

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J4-4563
Naslov:Uporaba izboljšanega sistema CRISPR/Cas za ne-virusno produkcijo celic CAR-T

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj